MEMP1972A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MEMP1972A, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA) [Phase 2]

See pricing